中央静脉征及其在多发性硬化诊断中的临床评估:北美多发性硬化影像合作组的共识声明
该共识声明由北美多发性硬化影像合作组基于文献综述与成员共识制定,指出当前多发性硬化MRI诊断标准敏感度和特异度不完美,中央静脉征作为新型MRI生物标志物可能提高诊断准确性和速度,但缺乏标准化定义和成像限制其临床实施,文章提供声明和建议以帮助放射科和神经科医生理解、完善、标准化和评估中央静脉征。
要点
- 中央静脉征在单个病灶中的存在可准确区分多发性硬化与模拟疾病。
- 中央静脉征对疑似脱髓鞘疾病患者发展为临床多发性硬化的预测价值仍未知。
- 中央静脉征定义和成像缺乏标准化,目前限制其临床实施和验证。
核心结论
- 中央静脉征作为新型MRI生物标志物可能提高多发性硬化诊断的准确性和速度,但其对疑似脱髓鞘疾病患者发展为临床多发性硬化的预测价值仍未知,且缺乏标准化定义和成像限制临床实施和验证。
研究设计与样本
- 基于对现有中央静脉征文献的全面综述和北美多发性硬化影像合作组成员共识意见的共识声明。
关键影像表现/征象
- 中央静脉征在单个病灶中的存在可准确区分多发性硬化与模拟该病的其他疾病。
临床应用与阅片要点
- 文章提供声明和建议,旨在帮助放射科医生和神经科医生更好地理解、完善、标准化和评估中央静脉征在多发性硬化诊断中的应用。
局限性
- 中央静脉征对疑似脱髓鞘疾病患者发展为临床多发性硬化的预测价值仍未知。
- 中央静脉征的定义和成像缺乏标准化,目前限制其临床实施和验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Over the past few years, MRI has become an indispensable tool for diagnosing multiple sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and specificity. The central vein sign (CVS) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of the CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition. However, the predictive value of the CVS for the development of clinical MS in patients with suspected demyelinating disease is still unknown. Moreover, the lack of standardization for the definition and imaging of the CVS currently limits its clinical implementation and validation. On the basis of a thorough review of the existing literature on the CVS and the consensus opinion of the members of the North American Imaging in Multiple Sclerosis (NAIMS) Cooperative, this article provides statements and recommendations aimed at helping radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS.
引用
- Sati P, Oh J, Constable RT, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016. PMID: 27834394. doi:10.1038/nrneurol.2016.166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。